Advertisement
外汇新闻
Bird Global Appoints Joseph Prodan To Succeed Michael Washinushi As CFO
Electric transportation company Bird Global, Inc. (BRDS) announced Monday the appointment of Joseph (Joe) Prodan as Chief Financial Officer (CFO), effective August 30, 2023. Prodan succeeds Michael Washinushi, following his recent appointment to Interim CEO.
RTTNews |
639天前
Kellogg Board Approves Separation Into Two Independent, Publicly Traded Companies
Kellogg Co. (K) announced Monday that its Board of Directors formally approved the previously announced separation into two independent, publicly traded companies, Kellanova and WK Kellogg Co.
RTTNews
|
639天前
InflaRx Reports Positive Topline Results From SAD Phase I Study With C5aR Inhibitor INF904
Biotechnology company InflaRx N.V. (IFRX) announced Monday topline results from the single ascending dose (SAD) part of its randomized, double-blind, placebo-controlled Phase I trial of the orally administered, low molecular weight C5aR inhibitor INF904.
RTTNews
|
639天前
Bay Street Likely To Open Higher
Canadian shares are likely to open on a positive note on Monday, tracking European markets and higher bullion prices.
RTTNews
|
639天前
Welltower Boosts FY23 NFFO Guidance
Healthcare infrastructure company Welltower Inc. (WELL) on Monday raised its earnings guidance for the full-year 2023.
RTTNews
|
639天前
Moderna, Immatics Ink Strategic Multi-Platform Collaboration To Develop Oncology Therapeutics
Biopharmaceutical company Moderna, Inc. (MRNA) and Germany-based Immatics N.V. (IMTX) announced Monday a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need.
RTTNews
|
639天前
Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis
Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Monday positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-279, an investigational oral allosteric tyrosine kinase 2 (TYK2) inhibitor with next generation selectivity, in people with active psoriatic arthritis.
RTTNews
|
639天前
more news
Sensex, Nifty Extend Winning Streak As Adani And PSU Stocks Climb
Indian shares extended their winning streak for the seventh day running on Monday, as enthusiasm over the G20 Summit outweighed muted cues from global markets.
RTTNews
|
639天前
Alibaba Stock Down As Former CEO Daniel Zhang Quits Cloud Unit
Shares of Alibaba Group Holding Ltd. dropped around 3 percent in Hong Kong trading after the Chinese e-commerce major announced the departure of Daniel Zhang, former chief executive officer, as the head of its cloud business. The move comes as the cloud business reportedly is preparing for its IPO. In a statement, the company now said that Eddie Yongming Wu, the newly appointed CEO, will succeed
RTTNews
|
639天前
Yen Extends Rise On BoJ Governor Ueda Comments
The Japanese yen extended its early gain against other major currencies in the European session on Monday, as traders sentiment boosted after the remarks from the Bank of Japan Governor Kazuo Ueda that the central bank could end its negative interest rate policy.
RTTNews
|
639天前
Indian Rupee Rises To 6-day High Against U.S. Dollar
The Indian rupee climbed against the U.S. dollar in evening deals on Monday.
RTTNews
|
639天前
European Shares Gain On China Optimism
European stocks traded higher on Monday after the latest inflation data from China stoked optimism about easing deflationary pressures in the world's second-largest economy.
RTTNews
|
639天前
FTSE 100 Edges Higher On China Optimism
U.K. stocks were moving higher on Monday after data showed China's consumer prices returned to positive territory in August while factory-gate price declines slowed - adding to signs of easing deflationary pressures in the world's second-largest economy.
RTTNews
|
639天前
Stay up to date!
Add 新闻 to your browser
Add To Chrome
